What is hidden behind a pulmonary hypertensive, fibrotic and inflammatory phenotype?

Eur Respir J. 2022 Oct 20;60(4):2201301. doi: 10.1183/13993003.01301-2022. Print 2022 Oct.

Authors

Serge Adnot^{1

2}, Larissa Lipskaia³, Oliver Bischof³

Affiliations

¹ INSERM U955 and Département de Physiologie, Hôpital Henri Mondor, FHU SENEC, AP-HP, 94010, Université Paris-Est Créteil (UPEC), Créteil, France serge.adnot@inserm.fr.
² Institute for Lung Health, Justus Liebig University, Giessen, Germany.
³ INSERM U955 and Département de Physiologie, Hôpital Henri Mondor, FHU SENEC, AP-HP, 94010, Université Paris-Est Créteil (UPEC), Créteil, France.

PMID: 36265871
DOI: 10.1183/13993003.01301-2022

No abstract available

Publication types

Editorial
Comment

MeSH terms

Animals
Mice
Phenotype
Pulmonary Fibrosis*
Pyridones
Scleroderma, Systemic*

Substances

pirfenidone
Pyridones